HSBC Holdings
IBER

HSBC Holdings’s Ibere Pharmaceuticals IBER Stock Holding History

HSBC Holdings’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-325,108
Closed -$3.28M – 3246
2022
Q4 		$3.28M Buy
+325,108
New +$3.25M ﹤0.01% 1471

HSBC Holdings's IBER Position: Q1 2023 in Review

HSBC Holdings sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 325,108 shares — an estimated $3.28M sold.

HSBC Holdings first reported a position in IBER in Q4 2022 and held it in 1 quarter. The position peaked at $3.28M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

  • HSBC Holdings reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 325,108 Ibere Pharmaceuticals shares in Q1 2023, an estimated $3.28M.
  • HSBC Holdings first reported a position in Ibere Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • HSBC Holdings's Ibere Pharmaceuticals position peaked at $3.28M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.